Asthma Research
NIMBLE Study
A 52-Week Study to Compare a New Drug (GSK3511294) with Mepolizumab or Benralizumab in Adolescents with Severe Asthma
AGE: 12+ years old
SEX AT BIRTH: All
SEX AT BIRTH: All
TYPE: Interventional Treatment Study
HEALTHY PARTICIPANTS: No
HEALTHY PARTICIPANTS: No
CONDITION: Asthma
LOCATION: University Hospitals Cleveland Medical Center
LOCATION: University Hospitals Cleveland Medical Center
Learn More About This Research Study
For more information, please contact study coordinator, Emily Witte at 216-286-6274 and leave a message or complete the online form below.
Study Purpose
The purpose of this study is to compare the investigational study drug, GSK3511294 with either mepolizumab or benralizumab for the treatment of asthma.
Who Can Participate
Participants with severe asthma that has been controlled with mepolizumab or benralizumab may be eligible for this study.